Horizon Investments’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.79M | Sell |
14,313
-664
| -4% | -$129K | 0.03% | 402 |
|
|
2025
Q4 | $2.59M | Buy |
14,977
+288
| +2% | +$52.4K | 0.03% | 412 |
|
|
2025
Q3 | $2.79M | Buy |
14,689
+2,807
| +24% | +$498K | 0.04% | 369 |
|
|
2025
Q2 | $2.12M | Buy |
11,882
+10,277
| +640% | +$1.79M | 0.03% | 372 |
|
|
2025
Q1 | $270K | Buy |
1,605
+82
| +5% | +$13.5K | 0.01% | 489 |
|
|
2024
Q4 | $229K | Buy |
1,523
+12
| +0.8% | +$1.87K | 0.01% | 510 |
|
|
2024
Q3 | $233K | Sell |
1,511
-165
| -10% | -$24.6K | 0.01% | 512 |
|
|
2024
Q2 | $228K | Buy |
1,676
+4
| +0.2% | +$548 | 0.01% | 522 |
|
|
2024
Q1 | $221K | Buy |
1,672
+50
| +3% | +$6.49K | 0.01% | 530 |
|
|
2023
Q4 | $222K | Buy |
1,622
+12
| +0.7% | +$1.58K | 0.01% | 503 |
|
|
2023
Q3 | $195K | Sell |
1,610
-13
| -0.8% | -$1.73K | 0.01% | 516 |
|
|
2023
Q2 | $227K | Sell |
1,623
-217
| -12% | -$29.9K | 0.01% | 485 |
|
|
2023
Q1 | $259K | Sell |
1,840
-1,141
| -38% | -$163K | 0.01% | 440 |
|
|
2022
Q4 | $464K | Buy |
2,981
+673
| +29% | +$96.7K | 0.01% | 383 |
|
|
2022
Q3 | $282K | Buy |
2,308
+363
| +19% | +$47.8K | 0.01% | 416 |
|
|
2022
Q2 | $257K | Sell |
1,945
-253
| -12% | -$34.5K | 0.01% | 402 |
|
|
2022
Q1 | $299K | Sell |
2,198
-1,251
| -36% | -$174K | 0.01% | 447 |
|
|
2021
Q4 | $594K | Buy |
3,449
+241
| +8% | +$36.7K | 0.02% | 297 |
|
|
2021
Q3 | $464K | Buy |
3,208
+933
| +41% | +$137K | 0.01% | 333 |
|
|
2021
Q2 | $299K | Sell |
2,275
-13,036
| -85% | -$1.71M | 0.01% | 396 |
|
|
2021
Q1 | $1.97M | Buy |
+15,311
| New | +$1.89M | 0.07% | 123 |
|
|
2020
Q4 | – | Sell |
-3,971
| Closed | -$452K | – | 160 |
|
|
2020
Q3 | $452K | Buy |
+3,971
| New | +$469K | 0.02% | 303 |
|
|
2020
Q1 | – | Sell |
-2,849
| Closed | -$304K | – | 337 |
|
|
2019
Q4 | $304K | Buy |
+2,849
| New | +$297K | 0.01% | 398 |
|
|
2019
Q3 | – | Sell |
-2,417
| Closed | -$246K | – | 436 |
|
|
2019
Q2 | $246K | Sell |
2,417
-21,923
| -90% | -$2.11M | 0.01% | 468 |
|
|
2019
Q1 | $2.18M | Buy |
24,340
+1,542
| +7% | +$134K | 0.08% | 127 |
|
|
2018
Q4 | $1.9M | Buy |
+22,798
| New | +$2.14M | 0.1% | 95 |
|
|
2018
Q3 | – | Sell |
-12,130
| Closed | -$1.33M | – | 265 |
|
|
2018
Q2 | $1.33M | Buy |
+12,130
| New | +$1.26M | 0.06% | 106 |
|
|
2017
Q4 | – | Sell |
-5,803
| Closed | -$618K | – | 190 |
|
|
2017
Q3 | $618K | Buy |
+5,803
| New | +$616K | 0.04% | 117 |
|
|
2017
Q1 | – | Sell |
-7,013
| Closed | -$644K | – | 167 |
|
|
2016
Q4 | $644K | Buy |
+7,013
| New | +$604K | 0.04% | 91 |
|
Other funds holding DGX
VCM
VPM
EIG
Horizon Investments's DGX Position: Q1 2026 in Review
Horizon Investments reduced its Quest Diagnostics (DGX) stake by 4.4% in Q1 2026, selling an estimated $129K and leaving 14,313 shares worth $2.79M. The position accounts for 0.03% of the portfolio, ranked #402.
Horizon Investments first reported a position in DGX in Q4 2016 and has held it in 29 quarters since. 1,066 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Horizon Investments held 14,313 shares of Quest Diagnostics worth $2.79M as of Q1 2026.
- Horizon Investments sold 664 Quest Diagnostics shares in Q1 2026, an estimated $129K.
- Quest Diagnostics made up 0.03% of Horizon Investments's portfolio in Q1 2026, its #402 holding.
- Horizon Investments first reported a position in Quest Diagnostics in Q4 2016 and has held it in 29 quarters since.
- 1,066 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Horizon Investments's 13F filing for Q1 2026, filed 15 May 2026.